Seth Lederman Insider Profile

Seth Lederman, CEO, Director at Tonix Pharma, holds 27.75K shares in Tonix Pharma (Ticker: TNXP). Most recently, Seth Lederman Bought $20,000 shares of Tonix Pharma on Jul 01, 2022 for an estimated value of 34.20K.
Seth Lederman

Seth Lederman
Tonix Pharma (TNXP)
CEO, Director

Ranked #95,223 out of 97,311 Corporate Insiders

Profitable Transactions

4 out of 31 Profitable Transactions

Average Return

Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of Seth Lederman's holdings

Insider Roles

Tonix Pharma
CEO, Director
Roles that Seth Lederman holds in companies

Most Profitable Insider Trade

Tonix Pharma
Rating:Informative Buy
Date:Jun 20, 2017 - Jun 20, 2018
The most profitable trade made by Seth Lederman

Seth Lederman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tonix Pharma
Jul 01, 2022
CEO, Director
Informative Buy
Success Rate for TNXP
4 out of 31 profitable transactions on TNXP
Average Return for TNXP
Average return per transaction on TNXP
No. of Shares
Price per Share
Link to Report
Jan 14, 2013
Informative Buy
Mar 05, 2015
Informative Buy
Mar 09, 2015
Informative Buy
Mar 13, 2015
Informative Buy
Aug 15, 2013
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Seth Lederman's performance on stock

Seth Lederman insider profile FAQ

What is the percentage of profitable transactions made by Seth Lederman?
The percentage of profitable transactions made by Seth Lederman is 13%.
    What is the average return per transaction made by Seth Lederman?
    The average return per transaction made by Seth Lederman is -66.10%.
      What stocks does Seth Lederman hold?
      Seth Lederman holds: TNXP stocks.
        What was Seth Lederman’s latest transaction?
        Seth Lederman latest transaction was an Informative Buy of $34.20K.
          What was Seth Lederman's most profitable transaction?
          Seth Lederman’s most profitable transaction was an Informative Buy of TNXP stock on June 20, 2017. The return on the trade was 14.10%.
            What is Seth Lederman's role in Tonix Pharma?
            Seth Lederman's role in Tonix Pharma is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.